z-logo
open-access-imgOpen Access
<p>Differential Expression And Effects Of Peroxiredoxin-6 On Drug Resistance And Cancer Stem Cell-Like Properties In Non-Small Cell Lung Cancer</p>
Author(s) -
Jiaman Xu,
Qiang Su,
Mingxia Gao,
Qingsong Liang,
Junfeng Li,
Xu Chen
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s211125
Subject(s) - cisplatin , cancer stem cell , wnt signaling pathway , cancer research , lung cancer , flow cytometry , gene silencing , viability assay , abcg2 , immunohistochemistry , cancer , cell , chemistry , microbiology and biotechnology , biology , medicine , pathology , signal transduction , chemotherapy , biochemistry , atp binding cassette transporter , transporter , gene
Cancer stem-like cells (CSC) are thought to be involved in the cisplatin resistance of tumors. This study was designed to investigate the effect of PRDX6 on CSCs present in cisplatin-resistant non-small cell lung cancer (NSCLC) tumors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here